Laparoscopic placement of hepatic artery catheter for regional chemotherapy infusion: Technique, benefits, and complications

Surgical Laparoscopy, Endoscopy and Percutaneous Techniques

Volumn 12, Issue 6, 2002, Pages 398-407

  Franklin Jr , Morris E ^a,c   Gonzalez Jr , John J ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Texas Endosurgery Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; METHYLENE BLUE;

ADULT; AGED; ARTERY CATHETER; ARTERY CATHETERIZATION; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER REGRESSION; CANCER SURVIVAL; CHOLECYSTECTOMY; CLINICAL ARTICLE; COLON RESECTION; COLORECTAL CANCER; DRUG INFUSION; FEMALE; HEPATIC ARTERY; HUMAN; LAPAROSCOPIC SURGERY; LENGTH OF STAY; LIVER METASTASIS; LIVER RESECTION; MALE; MINIMALLY INVASIVE SURGERY; OPERATION DURATION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CATHETERIZATION, PERIPHERAL; COLORECTAL NEOPLASMS; FEMALE; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LAPAROSCOPY; LIVER NEOPLASMS; MALE; MIDDLE AGED; SUTURE TECHNIQUES;

EID: 0036914194     PISSN: 10517200     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129689-200212000-00003     Document Type: Article

References (33)

1. Weiss L, Grundmann E, Torhorst J, et al. Hematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies. J Pathol 1986;150:195-203.
2. Wagman LD, Kemeny NM, Leong L, et al. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 1990;8:1885-93.
3. Kemeny N, Daly J, Reichmann B, et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma: A randomized trial. Ann Intern Med 1987;107:459-65.
4. Chang AE, Schneider PD, Sugarbaker PH, et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987;206:685-93.
5. Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial. J Clin Oncol 1989;7:1646-54.
6. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long term results of a prospective, randomized trial. J Clin Oncol 1992;10:1112-8.
7. Martin JK Jr, O'Connell MJ, Wieand HS, et al. Intra-arterial floxuridine versus systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 1990;125:1022-7.
8. Allen-Mersh TG, Earlam S, Fordy C, et al. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994;344:1255-60.
9. Kemeny N, Huang Y, Cohen AM, et al, Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer, N Engl J Med 1999;341:2039-48.
10. Harmantas A, Rotstein LE, Langer B. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver: Is there a survival difference? Meta-analysis of the published literature. Cancer 1996;78:1639-45.
11. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer: Meta-Analysis Group in Cancer. J Natl Cancer Inst 1996;88:252-8.
12. Breedis C, Young G. The blood supply of neoplasms of the liver. Am J Pathol 1954;30:969-74.
13. Chen HS, Gross JF. Intra-arterial infusion of anticancer drugs: Theoretical aspects of drug delivery and review of responses. Cancer Treat Rep 1980;64:31-40.
14. Franklin ME Jr., Norem RF, Stubbs R. Laparoscopic approach for regional hepatic chemotherapy in the treatment of primary or metastatic malignancy. In: Green FL, Rosen RD, eds. Minimal Access Surgical Oncology. New York: Radcliffe Medical Press, 1995:153-7.
15. Reed ML, Vaitkevicius VK, Al-Sarraf M, et al. The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: Ten-year results in 124 patients in a prospective protocol. Cancer 1981;47:402-9.
16. Clouse ME, Ahmed R, Ryan RB, et al. Complications of long term transbrachial hepatic arterial infusion. AJR 1977;129:799-803.
17. Watkins E, Khazei AM, Nahra KS. Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver. Surg Gyn Oncol 1970;130:581-605.
18. Feliciotti F, Paganini A, Guerrieri M, et al. Laparoscopic intraarterial catéter implantation for regional chemotherapy of liver metastasis. Surg Endosc 1996;10:449-52.
19. Urbach DR, Hansen PD. Laparoscopic placement of a continuous hepatic artery infusion pump. Semin Laparosc Surg 2000;7:140-7.
20. Urbach DR, Herron DM, Khajanchee YS, et al. Laparoscopic hepatic artery infusion pump placement. Arch Surg 2001;136:700-4.
21. Cady B. Hepatic arterial patency and complications after catheterization for infusion chemotherapy. Ann Surg 1973;178:156-61.
22. Cherqui D, Garden OJ, Bismuth H. Duodenal erosion complicating an implanted hepatic arterial access device. Br J Surg 1988;75:556.
23. Clark RA, Gallant TE. Bile duct strictures associated with hepatic arterial infusion chemotherapy. Gastrointest Radiol 1987;12:148-51.
24. Doria MI Jr, Doria LK, Faintuch J, et al. Gastric mucosal injury after hepatic arterial infusion chemotherapy with floxuridine: A clinical and pathologic study. Cancer 1994;73:2042-7.
25. Fukuzumi S, Moriya Y, Makuuchi M, et al. Serious chemical sclerosing cholangitis associated with hepatic arterial 5 FU and MMC chemotherapy. Eur J Surg Oncol 1990;16:251-5.
26. Hohn DC, Rayner AA, Economou JS, et al. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer 1986;57:465-70.
27. Ottery FD, Scupham RK, Weese JL. Chemical cholecystitis after intrahepatic chemotherapy: The case for prophylactic cholecystectomy during pump placement. Dis Colon Rectum 1986;29:187-90.
28. Shepard KV, Levin B, Faintuch J, et al. Hepatitis in patients receiving intraarterial chemotherapy for metastatic colorectal carcinoma. Am J Clin Oncol 1987;10:36-40.
29. Stagg RJ, Venook AP, Chase JL, et al. Alternating hepatic intraarterial floxuridine and fluorouracil: A less toxic regimen for treatment of liver metastases from colorectal cancer. J Natl Cancer Inst 1991;83:423-8.
30. Nelson TM, Pollak R, Jonasson O, et al. Anatomic variants of the celiac, superior mesenteric, and inferior mesenteric arteries and their clinical relevance. Clin Anat 1988;1:75-91.
31. Michels NA. Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg 1962;112:337-47.
32. Hiatt JR, Gabbay J, Busuttil RW. Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg 1994;220:50-2.
33. Rosen RJ. Angiography: General techniques, complications, and risk management. In: Taveras JM, Ferrucci JT, eds. Radiology. Vol. 2. Philadelphia: Lippincott-Raven Publishers, 1998:1-18.